Timothy C. Dec - 28 Feb 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Issuer symbol
SUPN
Transactions as of
28 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Mar 2025, 16:20:01 UTC
Previous filing
24 Feb 2025
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 14,091 28 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Performance Share Unit Award $0 +2,000 $0.000000 2,000 28 Feb 2025 Common Stock 2,000 $0.000000 Direct F1
transaction SUPN Performance Share Unit Award $0 +1,800 $0.000000 1,800 28 Feb 2025 Common Stock 1,800 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.
F2 On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.